Objectives: Oxygen tension affects the biology of aerobic and denitrifying organisms.
in cystic fibrosis (CF) patients. [1] [2] [3] [4] For example, there are regions of mucous in the CF airways that have profoundly low pO 2 as measured bronchoscopically. This has been attributed, in part, to increased O 2 consumption by CF airway epithelial cells. 3 Though controversial, chronic anaerobic infections are increasingly seen as damaging to the airway. [5] [6] [7] [8] [9] CF airway pathology classically begins in the distal airways. 10 We hypothesized that low pO 2 in the distal CF airways could be measured noninvasively, perhaps ultimately identifying risk for anaerobic or denitrifying infection. 11 Moreover, we hypothesized that nasal cannula oxygen would increase pO 2 to a measurable (and thus titratable) degree in the distal airway, potentially serving as an adjunctive therapy for patients with anaerobic distal airway infections.
Though integrated exhaled O 2 values are routinely measured to assess oxygen uptake in exercise physiology, 12 we were surprised that we could not identify any prior work measuring end-expiratory oxygen tension in health or disease. Therefore, we developed a novel system using a fast-response analyzer for continuous recording of O 2 and CO 2 tensions. We found that CF patients, overall, have lower exhaled O 2 than normal subjects at the residual volume (RV) nadir of fractional oxygen (NFO), at which CO 2 tension is >38 mmHg, and furthermore, that nasal cannula oxygen increases NFO linearly. Surprisingly, many asthma patients had low-normal NFO values as well, and primary ciliary dyskinesia (PCD) patients had higher levels. We believe these data have implications for understanding the complex ecology of the distal airway.
| MATERIALS AND METHODS

| Subjects
Subjects with CF 13 , PCD 14 or moderate or severe asthma 15 were outpatients, 10 years or older, recruited from Rainbow's Pulmonology Clinic. [13] [14] [15] Healthy controls were volunteers from faculty, staff, or Case
Western Reserve University students. Participants with a clinically documented disease exacerbation, intercurrent comorbid illness or hypoxia were excluded. This study was reviewed and approved by the University Hospitals Institutional Review Board. Informed consent and/ or assent were obtained from all participants or their legal guardians, as applicable. We sought a minimum of 15 subjects in each disease category, but were unable to achieve this recruitment goal for PCD patients. As we consider this to be a pilot study, we chose to keep our sample sizes limited.
We specifically chose to investigate oxygen concentration in the distal airways of CF patients in order to corroborate past research findings of steep oxygen gradients. 3 Furthermore, we sought to investigate oxygen tension among PCD and asthma patients as, to our knowledge, there is no current literature describing this value among these disease groups. Healthy volunteers were recruited as controls.
| Experimental procedure
Oxygen, CO 2 and airflow were measured using an O2CPX Fast Laser
Diode Oxygen Analyzer in series with a pneumotachometer and a CO 2 analyzer (Oxigraf, Mountain View, CA). Peripheral oxygen saturation (S a O 2 ) was measured using pulse oximetry (Masimo SET, RadV NFO was recorded when the fraction of exhaled CO 2 surpassed 5%, and also when the flow reached zero.
To investigate whether NFO could be increased with supplemental oxygen, three healthy subjects performed the procedure described above while receiving oxygen by nasal cannula at 0, 1, 2, 3, or 4 L/min after a 2 min exposure at each flow. Each participant completed three trials per flow rate.
| Spirometry
Spirometry was performed using a CareFusion spirometer according to ATS standards 16 for adults, and according to the standards adopted by the Cystic Fibrosis Foundation for children.
| Statistical analysis
Linear regression was used to model the relationship between NFO and S a O 2 , NFO and age, and NFO and FEV 1 , FEV 1 /FVC, and FEF (percent predicted). Pearson correlation coefficients were used to determine associations between variables. Means of continuous variables were compared between disease groups and healthy subjects using Tukey's Honest Significant Difference test. A P-value of <0.05
was considered significant. The statistical analyses were carried out in JMP Pro 12 (SAS Institute Inc., Cary, NC).
3 | RESULTS
| Subjects
Seventy-four subjects, 10-61 years old, completed the study. There were 29 control subjects, 23 subjects with CF, 15 subjects with asthma and seven subjects with PCD (Table 1) . No subjects had a pulmonary exacerbation or intercurrent illness, and all were normoxic (Table 1) .
Seven additional subjects (two CF, four asthma, and one control) were unable to perform the technique and were excluded from the analysis.
No relationship was found between NFO and age among all subjects (P = 0.31, R 2 = 0.014) or CF subjects in particular (P = 0.21, R 2 = 0.073);
therefore, pediatric and adult CF patient data were analyzed together.
| Peripheral oxygen saturation and NFO
No relationship was found between NFO and S a O 2 (P = 0.21, (Figure 1 ).
| NFO in health and disease
Cystic fibrosis patients had significantly lower average NFO values than healthy subjects (P = 0.0162). The mean NFO in CF was 12.4 ± 1.23%, as compared to 13.40 ± 1.09% in healthy subjects ( Figure 2 ). We found no difference in NFO values between asthma and CF patients (P = 0.0907), or between asthma patients and healthy subjects (P = 0.997). NFO for PCD (14.4% ± 0.59%) was significantly higher than CF (P = 0.0007), but not different from controls (P = 0.145) or asthma (P = 0.154).
We compared other parameters for measuring F EO2 in addition to the absolute nadir. There was also a significant difference in mean F EO2
between CF patients and healthy subjects at the time of the first consistent zero flow rate (12.6 ± 1.24%, 13.66 ± 1.06% P = 0.012), and there was a difference between CF and PCD (14.7 ± 0.64%, P = 0.001).
Using this method of evaluation, there were no other significant differences.
| Repeatability
Though we did not require repeatability, the three trials of all 29 control subjects were reproducible within 20% of one another, and most were reproducible within 10%. All but two CF subjects, 1 asthma subject and one PCD subject were reproducible within 20%.
Intersubject coefficients of variation were 8.1% in controls, 9.8% in CF, 8.2% in asthma and 4.1% in PCD.
| NFO and lung function
When all groups were compared together, there was a positive association between FEV 1 and NFO (P = 0.0009, R 2 = 0.24) ( Table 2) . When all groups were compared together there was a positive association between FEF and NFO (P = 0.016, R 2 = 0.14) ( Table 2 ). However, when each disease group was evaluated individually, FEF was positively associated with NFO only among CF patients (P = 0.017, R 2 = 0.25) and no NFO association was found among asthma or PCD patients (P = 0.85,R 2 = 0.003; P = 0.71, R 2 = 0.053) ( Table 2 ). 
| Effects of supplemental oxygen on NFO
| DISCUSSION
In this study, we introduce a novel, non-invasive measure: endexpiratory F EO2 . Surprisingly, we have not found any previous report measuring end-expiratory F EO2 or NFO. The development of our technique was facilitated by the availability of a novel, fast laser assay (with a response time of <200 ms) to record the decay of F EO2
between FRC and RV in real time. The results confirmed our hypotheses that distal airway F EO2 is lower in CF than healthy controls, and that it increases measurably with nasal cannula O 2 treatment. However, we unexpectedly observed that many asthma patients had low NFO levels, and that PCD NFO levels were higher than CF. Notably, we also observed that age was not a determinant of NFO. These data may have a number of potential implications.
The low NFO levels in CF could be consistent with the increased O 2 consumption by the CF epithelium reported by Worlitzsch. Nevertheless, we think additional mechanisms are relevant for three reasons. First, there was significant overlap between CF and controls.
Second, many asthma patients had levels similar to those observed in the low CF range, despite likely having more normal CFTR function.
Third, ventilation inhomogeneity was strongly suggested by the lack of association between NFO and peripheral oxygen saturation, 
FIGURE 3
There was a positive association between FEV1 and NFO among all disease groups (P = 0.0009, R 2 = 0.24)
FIGURE 4
Supplemental oxygen increased NFO in a dosedependent manner in all three healthy subjects: H10, H3, and H5 (P < 0.005, R 2 = 1.0; P < 0.005, R 2 = 0.98; P < 0.005, R 2 = 0.96) consistent with classical ventilation/perfusion matching: if NFO reflected homogeneously low distal airway oxygen, systemic arterial saturation should be low. We hypothesize that the partial occlusion of airways, as recently demonstrated by hyperpolarized gas MRI and CT studies [17] [18] [19] [20] results in regional alveolar hypoxia (the O 2 being low because alveolar gas is not readily refreshed during tidal breathing by atmospheric air). With forced expiration, slow emptying of these heterogeneous lung units located behind mucous plugs could account for low mixed F EO2 at RV. This hypothesis could also account for higher oxygen levels in PCD, given the thinner mucous in these airways as compared to CF and asthma (ie, the defect is not in mucous secretion, but in transport of thin mucous). It could also account for the general relationship between airflow obstruction and NFO, thus suggesting that mucous plugs could be a major contributor to low NFO.
Either way, the data support relatively low O 2 tension in the distal CF airway. Whether or not these low distal O 2 concentrations are uniform and reflect epithelial metabolism 3 and/or mucous plugging, the data support prior evidence that anaerobic growth may be favored in the CF airway microbiome. 3, [5] [6] [7] [8] [9] The anaerobes in the CF airway tend to be highly resistant to conventional antimicrobial treatment. 21 The results of this study were limited by sample size.
Fortunately, some subjects were able to perform the experimental procedure more consistently than others despite equal coaching and trials. The test proved reproducible, but future studies might be planned in which only measures within 10% of one another are accepted. Also, note that we did not have control childen, but the clear difference between results in asthma and PCD, despite similar ages, argues against age as a determinant of NFO values. This is the first study of its kind and is not a large population-based study:
future research may expand on sample size.
In conclusion, using a noninvasive technique, we have demon- 
